Lipodystrophy raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | GHRH analog family |
| Residue count | 44 amino acids | Matches human GHRH(1-44) backbone |
| N-terminal group | trans-3-hexenoyl | Main structural difference from native hormone |
| Appearance | White to off-white powder | Lyophilized solid form |
| Solubility class | Freely soluble in water | Peptide character; less soluble in organic solvents |
在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
The balance would, at least theoretically, actually decrease in size with heating to compensate for the lengthening of the hairspring. Through careful adjustment of the placement of the balance screws (brass or gold screws placed in the rim of the balance), a watch could be adjusted to keep time the same at both hot (100 °F (38 °C)) and cold (32 °F (0 °C)) temperatures. Unfortunately, a watch so adjusted would run slow at temperatures between these two. The problem was completely solved through the use of special alloys for the balance and hairspring which were essentially immune to thermal expansion. Such an alloy is used in Hamilton's 992E and 992B. Isochronism was occasionally improved through the use of a stopworks, a system designed to only allow the mainspring to operate within its center (most consistent) range. The most common method of achieving isochronism is through the use of the Breguet overcoil, which places part of the outermost turn of the hairspring in a different plane from the rest of the spring. This allows the hairspring to "breathe" more evenly and symmetrically. Two types of overcoils are found - the gradual overcoil and the Z-Bend. The gradual overcoil is obtained by imposing two gradual twists to the hairspring, forming the rise to the second plane over half the circumference; and the Z-bend does this by imposing two kinks of complementary 45 degree angles, accomplishing a rise to the second plane in about three spring section heights. The second method is done for esthetic reasons and is much more difficult to perform.
=== Philanthropy === Pfizer sponsors the Royal Society Pfizer Award and The Pfizer Award. In 2022, Pfizer launched the "An Accord for a Healthier World" initiative, which provides Pfizer's medicines and vaccines to 45 lower-income countries on a not-for-profit basis. Notable organizations to which Pfizer has provided funding include the Institute for Advanced Study, University of Toronto, and member of the President's Circle. University of Washington, Habitat for Humanity, Human Rights Campaign, National Women's Law Center, Share Our Strength, WaterAid, National Geographic, National Geographic Society, 94th Academy Awards, National Press Foundation, 19 to Zero, American Society of Hematology, Canadian Cancer Society, Canadian Paediatric Society, Endocrine Society, and European Society of Cardiology. Notable professional associations to which Pfizer has contributed include American Statistical Association, Canadian Association of Emergency Physicians, Canadian Medical Association, Canadian Pharmacists Association, Canadian Pharmacists Journal, Canadian Public Health Association, Ontario Medical Association, Centre for Addiction and Mental Health, Dana–Farber Cancer Institute, Hospital for Sick Children (SickKids), North Bay Regional Health Center, Princess Margaret Cancer Centre, Scarborough Health Network, Sinai Health Foundation, including Mount Sinai Hospital, Bridgepoint Active Healthcare, and the Lunenfeld-Tanenbaum Research Institute, Sunnybrook Health Sciences Centre – Donor.
The alcohol 3 was then converted into the acetate 4 via acetic anhydride-pyridine at room temperature with an overall yield of 90%. The acetate was then converted to the hydroxymethyl derivative 5 in three steps (1. TFA/room temperature; 2. ClCO2Et/Et3N-CH2Cl2/room temperature; 3. NaBH4/CH3OH-CH2Cl2/0 °C. Mesylation of 5 (MsCl/CH3OH-Et3N-CH2Cl2/0 °C), followed by lithium chloride treatment in DMF and hydrolysis (NaOCH3/CH3OH-CH2Cl2/room temperature) give the chloride 6 at a 95% overall yield. Adding phenyllithium slowly to a mixture of 6 and chloromethyl benzyl ether in excess in THF at 78 °C gave the benzylgliotoxin adduct 7 at 45% yield. Next, boron trichloride treatment of 7 in in methylene chloride at 0 °C yielded the gliotoxin anisaldehyde adduct 8 at 50% yield. Finally, acid oxidation of 8 followed by perchloric acid treatment in methylene chloride at room temperature yielded d,l-gliotoxin in a 65% yield. Spectroscopic analysis (NMR, ir, uv, MS) and TLC comparison showed that the synthetic substance was identical to natural gliotoxin. At least a couple of alternative syntheses are known to be reported in the pendant literature.
As of 8 July 2015, the High Court in Belgrade found that decree 392, issued by the Presidency of the Presidium of the National Assembly on 3 August 1947, which deprived King Peter II and other members of the House of Karađorđević of their citizenship, was null and void from the moment of its adoption, in the parts pertaining to Crown Prince Alexander, and that all of its legal consequences are thus null and void.
Sources: en.wikipedia.org
Such long, isolated helices can also be detected by other methods, such as dielectric relaxation, flow birefringence, and measurements of the diffusion constant. In stricter terms, these methods detect only the characteristic prolate (long cigar-like) hydrodynamic shape of a helix, or its large dipole moment.
The American black bear's generalist behavior allowed it to exploit a wider variety of foods and has been given as a reason why, of these three genera, it alone survived climate and vegetative changes through the last Ice Age while the other, more specialized North American predators became extinct. However, both Arctodus and Tremarctos had survived several other, previous ice ages. After these prehistoric ursids became extinct at the end of the Pleistocene, American black bears, brown bears and polar bears were the only remaining bears in North America.
== Downstream processing == After separation, an additional separation method may then be used, such as isoelectric focusing or SDS-PAGE. The gel will then be physically cut, and the protein complexes extracted from each portion separately. Each extract may then be analysed, such as by peptide mass fingerprinting or de novo peptide sequencing after in-gel digestion. This can provide a great deal of information about the identities of the proteins in a complex.
== Pathogenesis == The body uses glucose for energy. Without insulin, glucose is unable to enter the cells where it will be used for this and other anabolic ("building up") purposes, such as the synthesis of glycogen, proteins, and fatty acids. Insulin is also an active preventor of the breakdown or catabolism of glycogen and fat. The absence of sufficient insulin causes this breaking-down process to be accelerated; it is the mechanism behind metabolizing fat instead of glucose and the appearance of ketones. Since the glucose that normally enters the cells is unable to do so without insulin, it begins to build up in the blood where it can be seen as hyperglycemia or high blood glucose levels. The tubules of the kidneys are normally able to re-absorb glucose, but they are unable to handle and process the amount of glucose they are being presented with. At this point, which is called the renal threshold, the excess glucose spills into the urine (glycosuria), where it can be seen in urine glucose testing. It is the polyuria, or over-frequent urination, which causes polydipsia, or excessive water consumption, through an osmotic process. Even though there is an overabundance of glucose, the lack of insulin does not allow it to enter the cells. As a result, they are not able to receive nourishment from their normal glucose source. The body begins using fat for this purpose, causing weight loss; the process is similar to that of starvation.
=== EC 1.14.17 With reduced ascorbate as one donor, and incorporation of one atom of oxygen into the other donor === EC 1.14.17.1: dopamine β-monooxygenase EC |1.14.17.2: deleted, now included with EC 1.14.18.1 monophenol monooxygenase EC 1.14.17.3: peptidylglycine monooxygenase EC 1.14.17.4: aminocyclopropanecarboxylate oxidase
Sources: en.wikipedia.org
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.
It blocks the amino-terminal degradation step that limits native GHRH. The addition extends how long the peptide survives in plasma without removing its ability to activate the receptor.
The chain contains 44 amino acid residues. It matches the human GHRH(1-44) sequence apart from the amino-terminal modification.
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.